A STUDY TO EVALUATE PAZOPANIB IN COMPARISON TO PEMETREXED IN MAINTENANCE SETTING IN NON-PROGRESSING SUBJECTS WITH METASTATIC STAGE IVA AND IVB NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) POPULATION: